p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair.

CBP IBD Wnt colitis colorectal cancer p300

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Mar 2021
Historique:
received: 03 02 2021
revised: 07 03 2021
accepted: 10 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

Differential usage of Kat3 coactivators, CBP and p300, by β-catenin is a fundamental regulatory mechanism in stem cell maintenance and initiation of differentiation and repair. Based upon our earlier pharmacologic studies, p300 serine 89 (S89) is critical for controlling differential coactivator usage by β-catenin via post-translational phosphorylation in stem/progenitor populations, and appears to be a target for a number of kinase cascades. To further investigate mechanisms of signal integration effected by this domain, we generated p300 S89A knock-in mice. We show that S89A mice are extremely sensitive to intestinal insult resulting in colitis, which is known to significantly increase the risk of developing colorectal cancer. We demonstrate cell intrinsic differences, and microbiome compositional differences and differential immune responses, in intestine of S89A versus wild type mice. Genomic and proteomic analyses reveal pathway differences, including lipid metabolism, oxidative stress response, mitochondrial function and oxidative phosphorylation. The diverse effects on fundamental processes including epithelial differentiation, metabolism, immune response and microbiome colonization, all brought about by a single amino acid modification S89A, highlights the critical role of this region in p300 as a signaling nexus and the rationale for conservation of this residue and surrounding region for hundreds of million years of vertebrate evolution.

Identifiants

pubmed: 33799418
pii: cancers13061288
doi: 10.3390/cancers13061288
pmc: PMC7999107
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIH HHS
ID : K08AA025112
Pays : United States
Organisme : NIH HHS
ID : R21NS074392
Pays : United States
Organisme : NIAAA NIH HHS
ID : K08 AA025112
Pays : United States
Organisme : NIH HHS
ID : R01CA166161
Pays : United States
Organisme : Rotary Coins for Alzheimer's Research Trust (CART)
ID : N/A
Organisme : NIH HHS
ID : P30CA033572
Pays : United States
Organisme : NIH HHS
ID : R21AI105057
Pays : United States
Organisme : NIH HHS
ID : R01HL112638
Pays : United States

Références

Gene. 2013 May 10;520(1):14-21
pubmed: 23466978
Acta Pharm Sin B. 2015 Mar;5(2):135-44
pubmed: 26579439
Nucleic Acids Res. 2017 Jan 4;45(D1):D1107-D1111
pubmed: 27899654
ISME J. 2013 Jul;7(7):1256-61
pubmed: 23677008
Dev Growth Differ. 2002 Feb;44(1):77-84
pubmed: 11869294
EMBO J. 2003 Oct 1;22(19):5186-96
pubmed: 14517256
Cell. 1998 May 1;93(3):361-72
pubmed: 9590171
Nature. 2008 Nov 13;456(7219):269-73
pubmed: 18849969
Cell Host Microbe. 2015 May 13;17(5):662-71
pubmed: 25865369
Am J Gastroenterol. 2009 Jun;104(6):1435-44
pubmed: 19491857
Cell Metab. 2009 Nov;10(5):392-404
pubmed: 19883617
Trends Immunol. 2018 Jan;39(1):6-18
pubmed: 28923365
Cell. 1994 Jun 17;77(6):799-800
pubmed: 8004670
Carcinogenesis. 2013 Nov;34(11):2580-6
pubmed: 23843037
PLoS One. 2018 Jul 18;13(7):e0200714
pubmed: 30020971
Cell Host Microbe. 2018 Mar 14;23(3):338-352.e5
pubmed: 29503179
Prog Mol Biol Transl Sci. 2018 Jan;153:209-244
pubmed: 29389517
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12171-6
pubmed: 16093313
Cell Rep. 2018 Nov 13;25(7):1816-1828.e4
pubmed: 30428350
Future Med Chem. 2011 Oct;3(14):1745-63
pubmed: 22004083
Curr Biol. 1999 Dec 2;9(23):1415-8
pubmed: 10607566
Curr Mol Pharmacol. 2016;9(3):272-279
pubmed: 26008738
Carcinogenesis. 2005 Sep;26(9):1513-9
pubmed: 15860506
Genome Res. 2011 Mar;21(3):494-504
pubmed: 21212162
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1074-9
pubmed: 9037008
Nat Methods. 2013 Oct;10(10):996-8
pubmed: 23955772
J Biol Chem. 2016 Mar 18;291(12):6569-82
pubmed: 26833564
Cell Mol Gastroenterol Hepatol. 2017 Jan 24;3(3):422-446
pubmed: 28462382
Nat Genet. 2002 Feb;30(2):221-6
pubmed: 11818964
Cancers (Basel). 2018 Dec 19;10(12):
pubmed: 30572639
Nat Commun. 2015 Jun 02;6:7216
pubmed: 26031354
Inflamm Bowel Dis. 2015 Feb;21(2):378-84
pubmed: 25569733
Nature. 2003 Jan 9;421(6919):177-82
pubmed: 12483227
J Exp Med. 2001 May 7;193(9):1027-34
pubmed: 11342587
Mol Carcinog. 2007 Apr;46(4):315-29
pubmed: 17219422
Sci STKE. 2005 Feb 15;2005(271):cm1
pubmed: 15713948
Biochim Biophys Acta. 2002 Oct 21;1592(2):205-11
pubmed: 12379484
Mucosal Immunol. 2017 Jan;10(1):184-193
pubmed: 27220814
J Biol Chem. 2001 Oct 19;276(42):38341-4
pubmed: 11518699
Genes Dev. 2000 Feb 1;14(3):272-7
pubmed: 10673499
Oncogene. 2005 May 19;24(22):3619-31
pubmed: 15782138
Bio Protoc. 2016 Feb 20;6(4):
pubmed: 27570799
Nat Commun. 2018 Nov 7;9(1):4644
pubmed: 30405101
Cell Biol Toxicol. 2016 Feb;32(1):61-81
pubmed: 27008332
Inflamm Bowel Dis. 2017 Dec 19;24(1):136-148
pubmed: 29272487
Immunity. 2020 Aug 18;53(2):264-276
pubmed: 32814025
Genes Dev. 1994 Apr 15;8(8):869-84
pubmed: 7523245
BMC Gastroenterol. 2010 Nov 10;10:133
pubmed: 21067563
Annu Rev Immunol. 2010;28:573-621
pubmed: 20192811
Nature. 1997 Jun 12;387(6634):677-84
pubmed: 9192892
Science. 1998 Jan 30;279(5351):700-3
pubmed: 9445474
Biochem J. 2010 Mar 15;427(1):69-78
pubmed: 20141511
J Biol Chem. 2009 Sep 11;284(37):25149-59
pubmed: 19605937
J Vis Exp. 2010 Jan 19;(35):
pubmed: 20087313
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12682-7
pubmed: 15314234
Nat Commun. 2018 May 17;9(1):1982
pubmed: 29773794
Gastroenterology. 2017 Feb;152(2):327-339.e4
pubmed: 27769810
Int J Stem Cells. 2012 May;5(1):39-56
pubmed: 24298354
Oncogene. 2018 Oct;37(42):5587-5604
pubmed: 29915393
J Biol Chem. 2000 Dec 29;275(52):40946-51
pubmed: 11020388
Drug Discov Today. 2005 Nov 1;10(21):1467-74
pubmed: 16243267
Immunity. 2015 Mar 17;42(3):406-17
pubmed: 25786173
Adv Drug Deliv Rev. 2010 Sep 30;62(12):1149-55
pubmed: 20920541
Cell. 2006 Aug 25;126(4):801-10
pubmed: 16923398
Cell Host Microbe. 2020 Aug 12;28(2):273-284.e6
pubmed: 32668218
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15092-6
pubmed: 8986769
Inflamm Bowel Dis. 2007 Jul;13(7):807-21
pubmed: 17262812
J Cell Physiol. 2007 Dec;213(3):663-71
pubmed: 17559085
Methods Mol Biol. 2013;945:319-28
pubmed: 23097115
Carcinogenesis. 2009 Aug;30(8):1459-68
pubmed: 19502595
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5668-73
pubmed: 17372190
Science. 2006 Aug 25;313(5790):1126-30
pubmed: 16931762
Physiol Rev. 2001 Oct;81(4):1499-533
pubmed: 11581495
Cell. 2005 Jul 15;122(1):107-18
pubmed: 16009137
Curr Biol. 2010 Feb 23;20(4):316-21
pubmed: 20153195
Science. 2017 Aug 11;357(6351):570-575
pubmed: 28798125
Science. 2018 Nov 30;362(6418):
pubmed: 30498100
Int J Biochem Cell Biol. 2004 May;36(5):893-9
pubmed: 15006641
Nat Commun. 2020 Aug 28;11(1):4322
pubmed: 32859898

Auteurs

Keane K Y Lai (KKY)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

Xiaohui Hu (X)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

Keisuke Chosa (K)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

Cu Nguyen (C)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

David P Lin (DP)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

Keith K Lai (KK)

Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH 44195, USA.

Nobuo Kato (N)

The Institute of Scientific and Industrial Research, Osaka University, Osaka 567-0047, Japan.

Yusuke Higuchi (Y)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

Sarah K Highlander (SK)

Clinical Microbiome Service Center and Pathogen and Microbiome Division, Translational Genomics Research Institute, Flagstaff, AZ 86005, USA.

Elizabeth Melendez (E)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

Yoshihiro Eriguchi (Y)

Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

Patrick T Fueger (PT)

City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Department of Molecular and Cellular Endocrinology, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

Andre J Ouellette (AJ)

Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

Nyam-Osor Chimge (NO)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

Masaya Ono (M)

Department of Clinical Proteomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.

Michael Kahn (M)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

Classifications MeSH